Andrea Mosca

ORCID: 0000-0001-7521-8467
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hemoglobinopathies and Related Disorders
  • Diabetes Management and Research
  • Iron Metabolism and Disorders
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Clinical Laboratory Practices and Quality Control
  • Erythrocyte Function and Pathophysiology
  • Neonatal Health and Biochemistry
  • Hemoglobin structure and function
  • Diabetes and associated disorders
  • Metabolism, Diabetes, and Cancer
  • Cardiovascular Function and Risk Factors
  • Advanced Glycation End Products research
  • Diabetes Treatment and Management
  • Blood groups and transfusion
  • Electrochemical sensors and biosensors
  • Cholinesterase and Neurodegenerative Diseases
  • Microfluidic and Capillary Electrophoresis Applications
  • Mass Spectrometry Techniques and Applications
  • Pesticide Exposure and Toxicity
  • Metabolism and Genetic Disorders
  • Diet, Metabolism, and Disease
  • Analytical Methods in Pharmaceuticals
  • Renal function and acid-base balance
  • Statistical Methods in Clinical Trials

University of Milan
2015-2024

Istituto per le Tecnologie Didattiche
1992-2023

Institute of Biomedical Technologies
1996-2023

National Research Council
2020-2023

University of Calabria
2023

World Health Organization Regional Office for the Eastern Mediterranean
2015-2019

Sociedade Brasileira de Psicologia
2018

Newmarket Equine Hospital
2017

Venice International University
2003-2015

Japan Research Institute
2015

Abstract Background: The national programs for the harmonization of hemoglobin (Hb)A1c measurements in US [National Glycohemoglobin Standardization Program (NGSP)], Japan [Japanese Diabetes Society (JDS)/Japanese Clinical Chemistry (JSCC)], and Sweden are based on different designated comparison methods (DCMs). future basis international standardization will be reference system developed by IFCC Working Group HbA1c Standardization. aim present study was to determine relationships between...

10.1373/clinchem.2003.024802 article EN Clinical Chemistry 2004-01-01

HbA 1c is the stable glucose adduct to N-terminal group of β-chain 0 . The measurement in human blood most important for long-term control glycaemic state diabetic patients. Because there was no internationally agreed reference method IFCC Working Group on Standardization developed a which here described. In first step haemoglobin cleaved into peptides by enzyme endoproteinase Glu-C, and second glycated non-glycated hexapeptides obtained are separated quantified HPLC electrospray ionisation...

10.1515/cclm.2002.016 article EN Clinical Chemistry and Laboratory Medicine (CCLM) 2002-01-29

The IFCC Reference Measurement System for hemoglobin (Hb)A(1c) (IFCC-RM) has been developed within the framework of metrologic traceability and is embedded in a network 14 reference laboratories. This paper describes outcome 12 intercomparison studies (periodic evaluations to control essential elements IFCC-RM).Each study included: unknown samples (to test individual laboratories); known (controls); recently manufactured calibrators check calculated assigned value); stored stability)...

10.1373/clinchem.2007.097402 article EN Clinical Chemistry 2008-01-25

The reference intervals for hemoglobin A1c (Hb A1c) in pregnant women without diabetes are not well defined, and few examples of established by networks different laboratories available.Five Italian Diabetic Care Units were involved the study. Data collected from 445 diabetes, selected on basis glucose challenge test results, 384 nonpregnant control women. Hb measurements performed with HPLC systems aligned to Diabetes Control Complications Trial. Plasma also locally. Both harmonized running...

10.1373/clinchem.2005.064899 article EN Clinical Chemistry 2006-04-07

Summary Although DNA analysis is needed for characterization of the mutations that cause β‐thalassaemia, measurement Hb A 2 essential routine identification people who are carriers β‐thalassaemia. The methods quantitating described together with pitfalls in undertaking these laboratory tests particular emphasis on automated high‐performance liquid chromatography and capillary electrophoresis.

10.1111/j.1751-553x.2011.01368.x article EN International Journal of Laboratory Hematology 2011-10-05

Summary Measurement of the Haemoglobin F in red cell haemolysates is important diagnosis δβ thalassaemia, hereditary persistence fetal haemoglobin (HPFH) and management sickle disease. The distribution Hb cells useful HPFH assessment feto‐maternal haemorrhage. methods quantifying are described together with pitfalls undertaking these laboratory tests particular emphasis on automated high‐performance liquid chromatography capillary electrophoresis.

10.1111/j.1751-553x.2011.01367.x article EN International Journal of Laboratory Hematology 2011-09-14

Abstract BACKGROUND A major objective of the IFCC Committee on Education and Use Biomarkers in Diabetes is to generate awareness improvement HbA1c assays through evaluation performance by countries manufacturers. METHODS Fresh whole blood lyophilized hemolysate specimens manufactured from same pool were used 17 external quality assessment organizers evaluate analytical 2166 laboratories. Results evaluated per country, manufacturer, manufacturer country combined according criteria model for...

10.1373/clinchem.2018.288795 article EN Clinical Chemistry 2018-06-19

Crocodilian hemoglobin has a high intrinsic oxygen affinity but does not react with those organic phosphate esters that normally control the of blood in higher vertebrates.Instead, its is greatly lowered by CO,.The present study was undertaken to determine nature COZ binding crocodilian species, Caiman, both qualitatively and quantitatively.The following parameters were measured: (a) carbamino compounds deoxy-and oxyhemoglobin, (b) effect (at constant pH) on Caiman hemoglobin, (c) total CO,...

10.1016/s0021-9258(19)68861-7 article EN cc-by Journal of Biological Chemistry 1981-08-01

Background: Point-of-care (POC) testing devices for monitoring glucose and ketones can play a key role in the management of dysglycemia hospitalized diabetes patients. The accuracy be influenced by biochemical changes that commonly occur critically ill hospital patients medication prescribed. Little is known about influence these factors on ketone POC measurements. aim this study was to assess analytical performance whole-blood meters extent interference design results. Methods: StatStrip...

10.1177/1932296814563351 article EN Journal of Diabetes Science and Technology 2014-12-17
Coming Soon ...